Table 3 Results of the multivariable logistic regression models for a binary outcome of experiencing smell and taste impairments during any time of the follow up (months 3 to 18).

From: Chemosensory assessment and impact on quality of life in neurosensorial cluster of the post COVID 19 syndrome

Name

Smell impairment

at follow-up

AUROC: 0.96

N = 982, 126 positive

Taste impairment

at follow-up

AUROC: 0.88

N = 989, 118 positive

OR

CI_low

CI_high

p-value

OR

CI_low

CI_high

p-value

Age

0.03

0.01

0.12

 < 0.001

0.01

0.0

0.03

 < 0.001

3rd wave

0.27

0.13

0.54

 < 0.001

    

Hospitalization

0.31

0.14

0.67

0.003

    

Monoclonal antibodies

0.41

0.19

0.9

0.027

0.53

0.27

1.01

0.054

Headache during acute COVID-19

0.55

0.3

1.02

0.059

0.8

0.46

1.37

0.417

2nd wave

0.63

0.3

1.34

0.231

1.46

0.78

2.75

0.237

Cardiovascular disease

0.75

0.38

1.48

0.412

    

Taste impairment during acute COVID-19

1.1

0.43

2.77

0.845

3.67

1.58

8.55

0.003

Female

1.14

0.61

2.14

0.679

0.97

0.57

1.65

0.902

Nasal congestion

during acute COVID-19

1.34

0.65

2.78

0.427

1.38

0.72

2.66

0.33

Smell impairment

during acute COVID-19

16.06

6.07

42.52

 < 0.001

1.81

0.78

4.22

0.167

  1. AUROC: area under the roc curve; OR: odd ratio; CI: confidence interval; COVID-19: COronaVIrus Disease 19.
  2. Significant values are in bold.
Back to article page